Replacement Therapy study 1 and the VA/NIH Acute Renal Failure Trial Network (ATN) study 2 —will certainly note that such increased intensity was not associated with improvement in outcomes.

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge from USD 1,214.6 billion in 2023 to an estimated USD 2,771.6 billion by ...